Core Insights - CVS Health has completed the acquisition of select Rite Aid assets, adding 63 stores and prescription files from 626 pharmacies, expanding access to over nine million patients [1][8] - The acquisition aligns with CVS's strategy to enhance pharmacy care access and grow its retail presence [1][8] - CVS participated in Rite Aid's bankruptcy process, which was initiated due to legal challenges and financial restructuring [2] CVS Health's Strategic Moves - CVS has hired over 3,500 former Rite Aid staff to ensure continuity in patient services and has made investments in existing locations to enhance service delivery [3][8] - The Pharmacy & Consumer Wellness segment has shown consistent revenue growth, benefiting from the increased prescription and front-store volume due to the Rite Aid acquisition [4][8] Market Performance - CVS Health shares have increased by 81.3% year-to-date, significantly outperforming the industry average growth of 0.5% [7] - The company is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 11.65X, which is lower than the industry average of 15.25X [9] Earnings Estimates - Current earnings estimates for CVS Health indicate a projected EPS of 6.36 for the year ending December 2025, with slight adjustments in quarterly estimates over the past 90 days [11]